ARTICLE | Company News
Minerva Biotechnologies, Kyoto University deal
September 7, 2015 7:00 AM UTC
The university’s technology transfer arm, iPS Academia Japan Inc., granted Minerva non-exclusive, worldwide rights to develop and commercialize iPS Academia’s induced pluripotent stem (iPS) cell pate...